Powder: -20°C for 3 years | In solvent: -80°C for 1 year
XR-11576 HCl is a novel orally active dual topoisomerase I and II inhibitor with antitumor activity.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 195.00 | |
5 mg | In stock | $ 430.00 | |
10 mg | In stock | $ 636.00 | |
25 mg | In stock | $ 987.00 | |
50 mg | In stock | $ 1,360.00 | |
100 mg | In stock | $ 1,830.00 | |
500 mg | In stock | $ 3,680.00 |
Description | XR-11576 HCl is a novel orally active dual topoisomerase I and II inhibitor with antitumor activity. |
Targets&IC50 | MRP:0.0121 µM, COR-L23 cells:0.0101 µM |
In vitro | XR-11576 has an inhibitory effect (IC50=0.0121 µ M) on multidrug-resistant human non-small cell lung cancer cell line COR-L23 (COR-L23/R) overexpressing multidrug-resistant protein (MRP).[1] |
Synonyms | XR-11576 HCl(346689-77-8 Free base) |
Molecular Weight | 424.92 |
Formula | C23H25ClN4O2 |
CAS No. | T26339L |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 45 mg/mL (105.9 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
XR-11576 HCl T26339L DNA Damage/DNA Repair Topoisomerase XR-11576 HCl(346689-77-8 Free base) inhibitor inhibit